Impact of Periodontal Therapy on Metabolic and Inflammatory Markers in Chronic Kidney Disease Patients.

Trial Profile

Impact of Periodontal Therapy on Metabolic and Inflammatory Markers in Chronic Kidney Disease Patients.

Completed
Phase of Trial: Phase II

Latest Information Update: 04 May 2012

At a glance

  • Drugs Minocycline (Primary)
  • Indications Bacterial infections; Dental infections; Periodontitis
  • Focus Pharmacodynamics
  • Acronyms KPU
  • Most Recent Events

    • 04 May 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 05 Feb 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 05 Feb 2010 Planned end date changed from 1 Dec 2009 to 1 Jun 2010 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top